Click on a filter below to refine your search. Remove a filter to broaden your search.
The findings were seen regardless of vaccination status and history of prior infection.
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
However, from 13 to 52 weeks after COVID-19, no increase was seen for diabetes mellitus or cardiovascular disease.